Skip to main content

Table 5 Class prediction of the common signature on training data

From: Large-scale integration of cancer microarray data identifies a robust common cancer signature

Microarray Platform

Study

Number of Normal Samples

Number of Cancer Samples

Accuracy (%)

P-value

HuGeneFL

Beer_Lung

10

86

95.8

8.87E-11

 

Dyrskjot_Bladder

4

40

95.5

1.18E-03

 

Hippo_Gastric

8

22

76.7

2.67E-01

 

Hsiao_Normal

59

0

91.5

N/A*

 

Lancaster_Ovarian

3

31

91.2

1.00

 

Logsdon_Pancreas

5

10

100

3.33E-04

 

Pomeroy_Brain

4

38

97.6

3.48E-04

 

Quade_Myometrium

4

14

77.8

2.29E-02

 

Ramaswamy_Multi

90

190

77.9

1.28E-20

 

Rickman_Brain

6

45

94.1

2.87E-04

 

Welsh_Ovarian

4

22

100

6.69E-05

 

Zhan_Myeloma

30

74

72.1

2.88E-01

 

Overall (HuGeneFL)

227

572

85.0

6.70E-68

HG-U95A

Bhattacharjee_Lung

17

47

90.6

6.34E-10

 

Cromer_Head-Neck

4

34

97.4

4.74E-04

 

Dehan_Lung

9

25

85.3

3.82E-05

 

Frierson_Salivary

6

16

95.5

9.38E-05

 

Giordano_Adrenal

3

11

92.9

1.10E-02

 

Gutmann_Brain

3

8

100

6.06E-03

 

Huang_Thyroid

8

8

75

5.59E-02

 

Shai_Brain

7

35

85.7

6.36E-05

 

Stearman_Lung

19

20

89.7

1.28E-07

 

Su_Multi

63

18

81.5

1.15E-05

 

Su_Tumors

0

154

93.5

N/A

 

Welle_Normal

12

0

100

N/A

 

Yanai_Normal

24

0

91.7

N/A

 

Yu_Prostate

16

35

54.9

1.83E-02

 

Overall (HG-U95A)

191

411

87.0

3.65E-77

  1. * For the data sets with samples from only one class, no p-value is available.